PVC Variability and Impact on Meeting Expert Consensus Cutoffs of ≥ 10 000 PVCs/Day and ≥ 15% PVCs.

Richard S Amara¹, Justin Brilliant¹, Jason Appelbaum¹, Ameer Abutaleb², Rama Vunnam¹, Stephen R Shorofsky¹, Jeffrey N Rottman¹, Ardit Kacorri³, Timm M Dickfeld¹

¹Division of Cardiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

²George Washington Transplant Institute, Washington, DC, USA.

³iRhythm Technologies Inc., San Francisco, California, USA.

PubMed DOI

Abstract

BACKGROUND: Frequent PVCs have been associated with a reversible cardiomyopathy. Cutoffs of ≥ 10 000 PVCs/day and ≥ 15% PVCs have been suggested by the 2014 EHRA/HRS/APHRS and 2017 AHA/ACC/HRS Expert Consensus guidelines, respectively, for PVC suppression. OBJECTIVE: To investigate the impact of PVC variability on meeting guideline-suggested PVC thresholds. METHODS: Six hundred and six patients…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.